Year: 2022
-
Feinberg Names New Executive Director for Research Facilities
Andrea Hall, PhD, a specialist microbiologist in the National Registry of Certified Microbiologists and a certified biosafety professional, is Feinberg’s new executive director for research facilities.
-
Gender Disparities in Publishing May be Widening for Physicians Due to COVID-19
A new Northwestern Medicine study has found men’s scholarly productivity increased, but women physicians were submitting less during the increase in work-from-home during the pandemic.
-
Rogers Honored by National Academy of Sciences
John Rogers, PhD, has been awarded the 2022 James Prize in Science and Technology Integration by the Council of the National Academy of Sciences.
-
Nano Bubbles Could Treat, Prevent Current and Future Strains Of SARS-Cov-2
A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
-
Medical Student Investigates Pre-Pregnancy Cardiovascular Health
Michael Wang, a fourth-year medical student, is the lead author of a study recently selected by the American Heart Association as one of the top heart disease and stroke research advances of 2021.
-
Balancing Act: The Science of Inflammation
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.
-
Nanotherapy Offers New Hope for the Treatment of Type 1 Diabetes
A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.
-
Without Coronary Calcium, Risk Factors Impact Cardiovascular Disease
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
-
Genome Editing Made Possible on Cells Lining Blood Vessel Walls
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
-
In Cancer Treatment, Quality of Life Matters More and More
A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.
